Vivimed Labs Limited (VIVIMEDLAB)
ISIN: INE526G01021 Industry: Drug Manufacturers—Specialty & Generic Sector: Healthcare Website
10.45
0.2(1.95%)

Vivimed Labs Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients (APIs), finished dosage formulations, specialty chemicals, and retail branded formulations in India, Mexico, Spain, Hungary, and internationally. It operates in two segments, Specialty Chemicals Business and Pharma Business. The company provides APIs and intermediates to generic and ethical companies; and branded formulations in therapeutic segments, such as ophthalmic, nutraceuticals, dermatology, and pain, as well as contract manufacturing of capsules and tablets, syrups and liquids, and nasal sprays and ointments. It also offers a range of hair dye intermediates for use in permanent, semi-permanent, and temporary hair colorant systems; oxidation dye couplers and bases to formulate various permanent and demi-permanent shades; direct dyes for semi-permanent formulations; and basic dyes for temporary, semi-permanent, and color-refresher shampoos and conditioners under the Jarocol name. In addition, the company manufactures and markets photochromic dyes under the Reversacol name; and anti-microbial actives for use in a range of applications, including plastics additives and anti-bacterial handwashes. Further, it offers photographic chemicals, such as black and white developers, and antifog additives for use in medical and industrial X-ray imaging, consumer photography, and litho-plate production for the graphic arts industry. Additionally, the company manufactures Favulous for the treatment of mild to moderate cases of Covid-19. Its products are used in home, personal, and industrial care segments. The company was incorporated in 1988 and is based in Hyderabad, India.

Pricing Updates

TODAY'S HIGH

10.5

TODAY'S LOW

10.25

52 WEEK HIGH

26.65

52 WEEK LOW

7.6

Major Holders

% of Shares Held by
All Insider

17.10%

% of Shares Held by
Institutions

12.82%

% of Float Held by
Institutions

15.46%

Number of Institutions
Holding Shares

2

Company Overview

MARKET CAP

86.64 Cr.

ETERPRISE VALUE

358.66 Cr.

NO. OF SHARES

8.29 Cr.

BOOK VALUE

43.913

DIV. YIELD

0.4%

DEBT

278.33 Cr.

GROSS PROFIT

85.07 Cr.

CASH

7.18 Cr.

REVENUE

238.55 Cr.

REVENUE/SHARE

28.775

OHLC Chart 1y 2y 5y 10y

Price Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Volumes Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Cashflows

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Investments198.82 Cr.-113.10 Cr.-83.20 Cr.18.90 Lakhs
Change To Liabilities3.06 Cr.-192.24 Cr.-67.92 Cr.92.43 Cr.
Total cashflows from Investing Activities523.34 Cr.403.99 Cr.-196.01 Cr.-88.87 Cr.
Net Borrowings29.39 Cr.-636.23 Cr.131.80 Cr.46.74 Cr.
Total Cash from Financing Activities-10.38 Cr.-1015.33 Cr.72.43 Cr.-337.79 Cr.
Other Liabilities-915.49 Cr.313.06 Cr.-17.81 Cr.248.79 Cr.
Total Assets0093.60 Lakhs93.60 Lakhs
Net Income-67.65 Cr.-77.79 Cr.-109.11 Cr.57.36 Cr.
Change in Cash-145.50 Cr.-44.05 Cr.-44.01 Cr.-4.52 Cr.
Effect of Exchange Rate0000
Total Cash from Operating Activities-658.46 Cr.567.27 Cr.79.56 Cr.422.13 Cr.
Depreciation18.28 Cr.55.49 Cr.66.93 Cr.66.79 Cr.
Other Cashflows from Investing Activities-30 k-30 k-30 k-30 k
Dividends Paid00-1.35 Cr.-317.27 Cr.
Change to Inventory159.88 Cr.246.22 Cr.61.77 Cr.-23.52 Cr.
Change to Account Receivables100.32 Cr.141.56 Cr.107.04 Cr.-80.68 Cr.
Other Cashflows from Financing Activities-39.77 Cr.-379.09 Cr.-58.95 Cr.-67.26 Cr.
Change to Net Income43.13 Cr.80.97 Cr.38.65 Cr.60.95 Cr.
Capital Expenditures00-112.80 Cr.-89.06 Cr.

Financials

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Research DevelopmentNoneNoneNoneNone
Effect of Accounting ChargesNoneNoneNoneNone
Income Before Tax-64.83 Cr.-75.76 Cr.-109.47 Cr.66.04 Cr.
Minority InterestNoneNoneNoneNone
Net Income-25.07 Cr.-21.88 Cr.-47.40 Cr.122.29 Cr.
Selling General Administrative36.22 Cr.195.65 Cr.241.21 Cr.248.60 Cr.
Gross Profit85.07 Cr.516.76 Cr.581.66 Cr.792.94 Cr.
Ebit-25.07 Cr.-21.88 Cr.-47.40 Cr.122.29 Cr.
Operating Income-25.07 Cr.-21.88 Cr.-47.40 Cr.122.29 Cr.
Other Operating Expenses55.64 Cr.287.50 Cr.320.89 Cr.355.25 Cr.
Interest Expense-39.76 Cr.-53.87 Cr.-58.14 Cr.-57.02 Cr.
Extraordinary ItemsNoneNoneNoneNone
Non RecurringNoneNoneNoneNone
Other ItemsNoneNoneNoneNone
Income Tax Expense2.81 Cr.2.02 Cr.-35.90 Lakhs8.68 Cr.
Total Revenue238.55 Cr.871.29 Cr.1067.05 Cr.1338.13 Cr.
Total Operating Expenses263.62 Cr.893.18 Cr.1114.45 Cr.1215.83 Cr.
Cost of Revenue153.48 Cr.354.52 Cr.485.39 Cr.545.18 Cr.
Total Other Income Expense Net-39.76 Cr.-53.87 Cr.-62.07 Cr.-56.25 Cr.
Discontinued OperationsNoneNoneNoneNone
Net Income from Continuous Ops.-67.65 Cr.-77.79 Cr.-109.11 Cr.57.36 Cr.
Net Income Applicable to Common Shares-67.65 Cr.-77.79 Cr.-109.11 Cr.57.36 Cr.

Balance Sheet

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Intangible Assets157.32 Cr.153.54 Cr.129.30 Cr.85.26 Cr.
Capital Surplus00231.38 Cr.230.52 Cr.
Total Liabilities901.72 Cr.857.75 Cr.1375.02 Cr.1385.37 Cr.
Stock Holder Equity364.28 Cr.431.57 Cr.509.37 Cr.618.57 Cr.
Minority Interest0000
Other Liabilities113.59 Cr.111.04 Cr.34.13 Cr.35.10 Cr.
Total Assets1266.01 Cr.1289.32 Cr.2209.61 Cr.2329.16 Cr.
Common Stock16.58 Cr.16.58 Cr.16.58 Cr.16.50 Cr.
Retained Earnings00238.18 Cr.348.32 Cr.
Other Liabilities467.34 Cr.458.88 Cr.134.27 Cr.71.63 Cr.
Good Will00217.62 Cr.217.62 Cr.
Treasury Stock347.70 Cr.414.99 Cr.23.22 Cr.23.22 Cr.
Other Assets-1 k32 k14.23 Cr.8.81 Cr.
Cash7.18 Cr.6.43 Cr.50.48 Cr.94.50 Cr.
Current Liabilities373.75 Cr.341.44 Cr.770.35 Cr.888.93 Cr.
Long Term Asset Charges0013.72 Cr.6.79 Cr.
Short Long Term Debt0053.78 Cr.197.60 Cr.
Other Stockholder Equity347.70 Cr.414.99 Cr.23.22 Cr.23.22 Cr.
Property Plant Equipment402.59 Cr.408.25 Cr.787.47 Cr.784.34 Cr.
Total Cur. Assets507.26 Cr.528.70 Cr.975.27 Cr.1230.60 Cr.
Long Term Investments198.82 Cr.198.82 Cr.85.71 Cr.2.51 Cr.
Net Tangible Assets206.95 Cr.278.03 Cr.162.44 Cr.315.68 Cr.
Short Term Investments0000
Net Receivables186.91 Cr.202.63 Cr.331.40 Cr.434.77 Cr.
Long Term Debt60.62 Cr.57.42 Cr.470.39 Cr.424.80 Cr.
Inventory240.76 Cr.255.68 Cr.501.90 Cr.563.68 Cr.
Accounts Payable41.89 Cr.34.25 Cr.226.50 Cr.294.42 Cr.

New Offers


Upstox offer
Upstox

Open a demat account through us and get the account opening charges waived off

open paperless account